Cargando…
Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Chronic Liver Disease
Patients with chronic liver diseases (CLDs) have high hospitalization and mortality rates when combined with severe coronavirus disease 2019 (COVID-19) because of defects in humoral and cellular immunity, known as immune dysfunction. COVID-19 vaccines effectively reduce the risk of severe illness an...
Autores principales: | Mao, Yu-Feng, Gao, Lin, Li, Yuan-Yuan, Wang, Fu-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368162/ http://dx.doi.org/10.1097/ID9.0000000000000094 |
Ejemplares similares
-
Efficacy and safety of SARS-CoV-2 vaccination in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022) -
Efficacy and safety of SARS-CoV-2 vaccines in living donor liver transplant recipients
por: Jadaun, Shekhar Singh, et al.
Publicado: (2022) -
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020) -
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
por: Chebel, Roy, et al.
Publicado: (2021) -
Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
por: Bian, Lianlian, et al.
Publicado: (2021)